Product Program year 2021 Source: CMS Open Payments

Follistim AQ

Drug Hormones

NDC 0052-0313-01

Open in the dashboard

General payments

$1,372

105 payments

Research payments

$0

0 payments

Through program year 2021, $1,372 in general payments and $0 in research payments were reported against Follistim AQ (Hormones).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

1 row
Year Kind Amount Payments
2021 General $1,372 105

Breakdown

Who paid General payments · program year 2021
  1. Organon LLC $1,372 105 payments
Top recipients General payments · program year 2021
  1. Althea O'Shaughnessy New York, NY $65 5% · 5 payments
  2. Deborah Smith Reproductive Endocrinology · Englewood, CO $59 4% · 7 payments
  3. John Wilcox Reproductive Endocrinology · Pasadena, CA $58 4% · 3 payments
  4. Natalia Grob Reproductive Endocrinology · Denver, CO $57 4% · 5 payments
  5. Susan Trout Reproductive Endocrinology · Denver, CO $51 4% · 3 payments

The top 5 of 63 recipients; each share is of general payments naming this product in 2021.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2021
  1. Reproductive Endocrinology Obstetrics & Gynecology $828 65% · 37 practitioners
  2. Nurse Practitioner, Family Nurse Practitioner $112 9% · 5 practitioners
  3. Nurse Practitioner, Women's Health Nurse Practitioner $99 8% · 4 practitioners
  4. Obstetrics & Gynecology $87 7% · 5 practitioners
  5. Nurse Practitioner $64 5% · 3 practitioners

The top 5 of 9 specialties; each share is of general payments naming this product to practitioners with a specialty in 2021. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2021
  1. Colorado $404 29% · 16 recipients
  2. California $276 20% · 13 recipients
  3. New York $169 12% · 6 recipients
  4. Kansas $91 7% · 4 recipients
  5. Utah $80 6% · 5 recipients

The top 5 of 16 states; each share is of general payments naming this product in 2021 where a state was reported.

The top 25 states, free in the app

105 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2021

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record